General
Preferred name
BOLDINE
Synonyms
1,10-Dimethoxy-2,9-dihydroxyaporphine ()
ex Peumus boldus ()
1, 10-Dimethoxy-2, 9-dihydroxyaporphine ()
P&D ID
PD017294
CAS
476-70-0
Tags
available
drug candidate
Drug indication
Discovery agent
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Boldine is an apomorphine isoquinoline alkaloid extracted from the root of the pheasant pepper (Litsea cubeba). Boldine is an oral effective antioxidant, anti-inflammatory, antitumor agent, and can inhibit osteoclast formation. Boldine induces apoptosis of human bladder cancer cells by regulating ERK, AKT and GSK-3¦Â. Boldine ameliorates bone destruction by down-regulating the OPG/RANKL/RANK signaling pathway. It can be used in rheumatoid arthritis research[1][2][3].
PRICE 29
DESCRIPTION Boldine (1,10-Dimethoxy-2,9-dihydroxyaporphine) is a natual product .Boldine displays anti-cancer, cytoprotective , anti-oxidant and anti-inflammatory activities. (TargetMol Bioactive Compound Library)
Compound Sets
5
Cayman Chemical Bioactives
DrugMAP
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
26
Properties
(calculated by RDKit )
Molecular Weight
327.15
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
4
Aromatic Ring Count
2
cLogP
2.87
TPSA
62.16
Fraction CSP3
0.37
Chiral centers
1.0
Largest ring
6.0
QED
0.89
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
NF-κB
NF-¦ÊB
Target
Apoptosis
RANKL/RANK
Adrenergic Receptor
OPG
RANK
RANKL
Source data